Evidence map›Paper›PMID 33936050›Full record

ArticleFrontiers in immunology2021

Lipoxin A4 Restores Septic Renal Function

Chaojin Chen, Rongzong Qiu, Jing Yang, Qian Zhang, Guoliang Sun, Xiaofeng Gao, Ziqing Hei, Haocong Ji

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. High-mobility group box 1 in acute kidney injury.Frontiers in pharmacology · 2025
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Dose-dependent multi-organ injury following lipopolysaccharide gas inhalation.The Journal of international medical research · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chaojin ChenDepartment of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Rongzong QiuDepartment of Anesthesiology, Guangdong Medical University, HuiZhou First Hospital, Huizhou, China.
Jing YangDepartment of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Qian ZhangDepartment of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Guoliang SunDepartment of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Xiaofeng GaoDepartment of Anesthesiology, Guangdong Medical University, HuiZhou First Hospital, Huizhou, China.
Ziqing HeiDepartment of Anesthesiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Haocong JiDepartment of Anesthesiology, Guangdong Medical University, HuiZhou First Hospital, Huizhou, China.
Sun Yat-sen University · CNGuangdong Medical College · CNThird Affiliated Hospital of Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) occurs in half of patients with septic shock, resulting in unacceptably high mortality. However, effective preventive treatments are still lacking. We hypothesized that pretreatment with lipoxin A4 (LXA4), known to promote inflammation resolution, may attenuate septic AKI

Indexed as

Acute Kidney InjuryAnimalsAnti-Inflammatory Agents, Non-SteroidalCell LineCellular SenescenceCyclin-Dependent Kinase Inhibitor p21LipoxinsMaleNF-kappa BPPAR gammaRatsRats, Sprague-DawleyShock, SepticTranscription Factor RelATumor Suppressor Protein p53Anti-Inflammatory Agents, Non-SteroidalCyclin-Dependent Kinase Inhibitor p21lipoxin A4LipoxinsNF-kappa BPPAR gammaRela protein, ratTp53 protein, ratTranscription Factor RelATumor Suppressor Protein p53acute kidney injurycellular senescenceinflammation resolutionlipoxin A4sepsis

Identifiers

PMID33936050
PMCPMC8084287
OpenAlexW3156674357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.